PUBLISHER: Euromonitor International | PRODUCT CODE: 1562084
PUBLISHER: Euromonitor International | PRODUCT CODE: 1562084
Digestive Remedies in Japan
As the impact of the COVID-19 pandemic subsided, eating and drinking outside the home recovered, as did long-distance domestic travel and overseas travel. Therefore, the retail current value growth trend for digestive remedies is set to continue in Japan in 2024, although growth will not be as sharp as in 2023.
Euromonitor International's Digestive Remedies in Japan report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2019-2023, allowing you to identify the sectors driving growth. Forecasts to 2028 illustrate how the market is set to change.
Product coverage: Diarrhoeal Remedies, IBS Treatments, Indigestion and Heartburn Remedies, Laxatives, Motion Sickness Remedies, Paediatric Digestive Remedies.
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report?
- Get a detailed picture of the Digestive Remedies market;
- Pinpoint growth sectors and identify factors driving change;
- Understand the competitive environment, the market's major players and leading brands;
- Use five-year forecasts to assess how the market is predicted to develop.
TABLE OF CONTENTS
List Of Contents And Tables
KEY DATA FINDINGS
2024 DEVELOPMENTS
- Digestive remedies maintains its growth trend, continuing its rebound from the pandemic
- Price revision for the leading player in diarrhoeal remedies
- Motion sickness remedies sees family-oriented promotions
PROSPECTS AND OPPORTUNITIES
- Various factors expected to drive a slowdown in growth
- Increase in retailers' private label lines and channels set to intensify the competition
- Potential for new cases of motion sickness from emerging technologies
CATEGORY DATA
- Table 1 Sales of Digestive Remedies by Category: Value 2019-2024
- Table 2 Sales of Digestive Remedies by Category: % Value Growth 2019-2024
- Table 3 NBO Company Shares of Digestive Remedies: % Value 2020-2024
- Table 4 LBN Brand Shares of Digestive Remedies: % Value 2021-2024
- Table 5 Forecast Sales of Digestive Remedies by Category: Value 2024-2029
- Table 6 Forecast Sales of Digestive Remedies by Category: % Value Growth 2024-2029
CONSUMER HEALTH IN JAPAN
EXECUTIVE SUMMARY
- Consumer health in 2024: The big picture
- 2024 key trends
- Competitive landscape
- Retailing developments
- What next for consumer health?
MARKET INDICATORS
- Table 7 Consumer Expenditure on Health Goods and Medical Services: Value 2019-2024
- Table 8 Life Expectancy at Birth 2019-2024
MARKET DATA
- Table 9 Sales of Consumer Health by Category: Value 2019-2024
- Table 10 Sales of Consumer Health by Category: % Value Growth 2019-2024
- Table 11 NBO Company Shares of Consumer Health: % Value 2020-2024
- Table 12 LBN Brand Shares of Consumer Health: % Value 2021-2024
- Table 13 Penetration of Private Label in Consumer Health by Category: % Value 2019-2024
- Table 14 Distribution of Consumer Health by Format: % Value 2019-2024
- Table 15 Distribution of Consumer Health by Format and Category: % Value 2024
- Table 16 Forecast Sales of Consumer Health by Category: Value 2024-2029
- Table 17 Forecast Sales of Consumer Health by Category: % Value Growth 2024-2029
APPENDIX
- OTC registration and classification
- Vitamins and dietary supplements registration and classification
- Self-medication/self-care and preventive medicine
- Switches
DISCLAIMER
DEFINITIONS
SOURCES
- Summary 1 Research Sources
